governmentEvidence level AIndependent
Evidence pageWarning Letter: US Stem Cell Clinic, LLC (524470)
U.S. Food and Drug Administration
Published Aug 24, 2017accessed Nov 10, 2026Updated Nov 10, 2026
Original source
fda.gov
Verification
| Verification | Independent of the subject |
| Evidence level | A · Government / regulator |
| Independent | Independent of the subject |
| Source | government |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (7)
FactSVF Breast Augmentation: US FDA position = Adipose-derived SVF fails the minimal-manipulation criterion (21 CFR 1271.10(a)(1)) and needs an IND or an approved BLA as a drug/biologicFactSVF Facial Fat Grafting: US regulatory position = FDA stated that processing adipose tissue into SVF is more than minimal manipulation, that the same-surgical-procedure exception does not apply, and that a BLA or IND is requiredAnswer日本では同じSVF豊胸を受けられますか?厚生労働省やPMDAの扱いはどうなっていますか?AnswerアメリカではSVFが規制されていると聞きましたが、どういう経緯ですか?AnswerSVF 가슴성형은 한국에서 합법인가요? 첨단재생의료 규제를 받나요?Answer这种SVF干细胞丰胸在中国大陆的正规医院能做吗?国内是怎么管的?Answerسمعت أن SVF ممنوع في الولايات المتحدة، فما القصة وهل ينطبق الأمر على السعودية والإمارات؟